News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
RxElite Enters Into a Development, Supply and Marketing Agreement for the Manufacture of an Ophthalmic Solution
July 14, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MERIDIAN, ID--(Marketwire - July 14, 2008) - RxElite, Inc. (OTCBB: RXEI) today announced the signing of a ten-year development, supply and marketing agreement with Hi-Tech Pharmacal Co., Inc., a manufacturer and marketer of liquid generic products.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
MORE ON THIS TOPIC
Layoff Tracker
Abata Shuts Down Amid Fundraising Difficulties
August 14, 2025
·
187 min read
·
BioSpace Editorial Staff
Layoffs
Vedanta Downsizes by 20% After Phase II Stumble in Ulcerative Colitis
August 14, 2025
·
2 min read
·
Tristan Manalac
PODCAST
The Hidden Patent Crisis That Could Break Biotech: What Every CEO Needs to Know
August 14, 2025
·
1 min read
·
Lori Ellis
Layoffs
Generation Bio Boots 90% of Staff Amid Dwindling Cash Reserves
August 13, 2025
·
2 min read
·
Tristan Manalac